Analyst Reco. 10x Genomics, Inc.

Equities

TXG

US88025U1097

Real-time Estimate Cboe BZX Other stock markets 11:39:45 2024-05-13 am EDT			5-day change	1st Jan Change
27.14 ^USD	+4.44%		+1.36%	-50.64%

May. 07	Bruker's NanoString Secures Patent Case Win in Germany	MT
May. 02	North American Morning Briefing : Stock Futures -2-	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UBS Adjusts 10x Genomics Price Target to $30 From $52, Maintains Neutral Rating	May. 01	MT
Canaccord Genuity Adjusts Price Target on 10x Genomics to $50 From $65, Maintains Buy Rating	Apr. 29	MT
Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating	Apr. 18	MT
UBS Adjusts 10x Genomics Price Target to $52 From $44, Maintains Neutral Rating	Feb. 21	MT
Stifel Cuts Price Target on 10x Genomics to $63 From $68, Maintains Buy Rating	Feb. 16	MT
Barclays Adjusts Price Target on 10x Genomics to $55 From $45, Maintains Overweight Rating	Jan. 25	MT
Wolfe Research Initiates 10x Genomics With Outperform Rating With $55 Price Target	Dec. 13	MT
BofA Securities Upgrades 10x Genomics to Neutral From Underperform, Adjusts Price Target to $54 From $36	Dec. 12	MT
UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating	Nov. 07	MT
Barclays Lowers Price Target on 10x Genomics to $47 From $66, Maintains Overweight Rating	23-09-29	MT
Citigroup Adjusts Price Target on 10x Genomics to $75 From $65, Maintains Buy Rating	23-08-04	MT
UBS Adjusts Price Target on 10x Genomics to $62 From $58, Maintains Neutral Rating	23-08-04	MT
Deutsche Bank Adjusts 10x Genomics Price Target to $65 From $56, Maintains Buy Rating	23-08-02	MT
Goldman Sachs Adjusts Price Target on 10x Genomics to $30 From $25, Maintains Sell Rating	23-07-13	MT
Barclays Initiates 10x Genomics at Overweight With $65 Price Target	23-05-10	MT
Stifel Nicolaus Adjusts 10x Genomics Price Target to $68 From $57, Maintains Buy Rating	23-05-04	MT
TD Cowen Adjusts Price Target on 10x Genomics to $66 From $62, Maintains Outperform Rating	23-05-04	MT
UBS Adjusts 10x Genomics Price Target to $58 From $54, Maintains Neutral Rating	23-05-04	MT
UBS Raises Price Target on 10x Genomics to $54 From $50, Keeps Neutral Rating	23-04-10	MT
Stephens Starts 10x Genomics at Overweight With $65 Price Target	23-03-31	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. 10x Genomics, Inc.

Equities

TXG

US88025U1097

Analyst Reco.

Filters